2021 CMSC Annual Meeting

OBSERVATIONAL STUDIES ARE IN THE EYE OF THE BEHOLDER

CREDITS: APA, CME, CNE, CPE, OT, PA, RD, SW
Expiration: 30-Apr-22
Level of Information: Intermediate

There is a critical gap in evidence regarding whether different treatment strategies early in relapsing multiple sclerosis prevent long-term disability, especially if a more aggressive treatment approach is warranted from the time of diagnosis, or if early escalation after a suboptimal treatment response to first-line therapies is adequate. Recent observational studies are providing a window into what may happen to people with MS years later with different treatments.

Presentations and Speakers

Introduction Scott D. Newsome, DO, MSCS, FAAN
Birds Eye View on Observational Studies Ellen Mowry, MD, MCR
Leveraging Real World Studies: Pros of Observational Studies Tomas Kalincik, MD, PhD, FRACP
Leveraging Real World Studies: Cons of Observational Studies Daniel Ontaneda, MD, PhD
Q & A Panel

You can only claim credits for this On-demand Video if you have not done so for the Live Event.